Phacilitate’s recent event brought together over 1500 senior executives from across the cell, gene, immunotherapy, stem cell and cord blood sectors for 5 days of networking and strategic discussions in the January sunshine.
"Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
Innovation Leader, GE Healthcare
“A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
Scientist, strategic partnerships, SQZ Biotech
"It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
Vice President, Head of Oncology Development, Incyte Corporation
"Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
Dr James Trager
Vice President, Research & Product Development, Dendreon
“In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”